AI to predict how bowel cancer patients will respond to new NHS drug

An AI tool called PhenMap has been developed to predict how advanced bowel cancer patients will respond to a new NHS drug, aiming to avoid ineffective treatments. Researchers from the Institute of Cancer Research and RCSI University of Medicine and Health Sciences collaborated on this method to improve patient outcomes.